Sign in and upgrade to a paid plan to export financials as CSV.

Poly Medicure Limited

Healthcare · Healthcare Equipment & Supplies

NSE: POLYMED BSE: 531768
₹1673.80
▲ 29.10 (1.77%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
75/100
Strong
Valuation
6/100
Expensive
Momentum
31/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹16,966 Cr
PE (TTM)
50.5
Industry median 50.5 (7 companies)
Price to Book
5.4
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
21.65%
FII + DII, latest filed period
Piotroski Score
3
Relative return vs Nifty50, qtr %
6.0
Relative return vs Sector, qtr %
4.4
Free Cash Flow
₹-68 Cr
as of March 31, 2026
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
0.12%
as of June 30, 2026
Industry median 27.06% (10 companies)
Net Profit Growth (TTM)
2.10%
as of June 30, 2026
Industry median 12.23% (8 companies)
Operating Revenue Growth (TTM)
9.24%
as of June 30, 2026
Industry median 8.86% (8 companies)
Profit Growth (YoY)
0.22%
as of June 30, 2026
Industry median 24.77% (9 companies)
Revenue Growth (YoY)
12.25%
as of June 30, 2026
Industry median 12.25% (11 companies)
Current Ratio
3.37
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
0.11
as of March 31, 2026
Industry median 0.11 (12 companies)
Interest Coverage
30.96
as of June 30, 2026
Industry median 12.12 (11 companies)
Net Margin
20.44%
as of June 30, 2026
Industry median 5.41% (10 companies)
Operating Margin (EBIT)
28.54%
as of June 30, 2026
Industry median 9.40% (11 companies)
Operating Margin (TTM)
27.17%
as of June 30, 2026
Industry median 13.81% (11 companies)
Return on Assets
8.18%
as of March 31, 2026
Industry median 4.45% (10 companies)
Return on Capital Employed
13.16%
as of March 31, 2026
Industry median 8.85% (11 companies)
Return on Equity
10.18%
as of March 31, 2026
Industry median 2.26% (9 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 3)
  • Yes Debt to equity is below 0.5 (0.11)
  • No Return on equity is 15% or more (10.2%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.8%
Low 1625.8000 · High 1684.5000
1W return
-3.1%
Low 1611.2000 · High 1772.0000
1M return
-4.9%
Low 1611.2000 · High 1858.0000
52W return
-14.2%
Low 1182.0000 · High 2094.3000
Lifetime High ₹3128.9000 (Nov. 1, 2024)
Lifetime Low ₹168.8500 (June 14, 2019)

Full price history and technicals →

EMA & SMA

Bullish2
Bearish4
5D
1675.1
10D
1689.9
20D
1705.6
50D
1701.9
100D
1661.5
200D
1574.6

Delivery and volume

Day avg. delivery
46.7%
Week avg. delivery
46.8%
Month avg. delivery
42.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1661.37
Pivot
First resistance1696.93
Second resistance1720.07
Third resistance1755.63
First support1638.23
Second support1602.67
Third support1579.53
Day RSI44.0
Day MFI44.9
Day MACD-15.45
Day MACD signal-8.07

Beta

1M1.13
3M0.90
1Y0.91
3Y0.83

Price change analysis

↓ -4.9%
Over 1 Month
LowHigh
1611.201858.00
↑ 0.5%
Over 3 Months
LowHigh
1605.601913.70
↑ 30.4%
Over 6 Months
LowHigh
1236.001913.70
↓ -14.2%
Over 1 Year
LowHigh
1182.002094.30
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 50.5 (own history: 35.9–80.8)
Buy Zone
Revenue (June 30, 2026)
₹431 Cr
Net profit (June 30, 2026)
₹88 Cr
Basic EPS (June 30, 2026)
₹8.6900

Ranks #1 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter62.42%
  • Mutual funds9.61%
  • FII/FPI5.57%
  • Other DII6.47%
  • Public15.93%

Largest holders

NameCategoryShares %Shares
EZEKIEL GLOBAL BUSINESS SOLUTIONS LLPPromoter12.2000%12361320
RISHI BAIDPromoter9.5900%9716356
ZETTA MATRIX CONSULTING LLPPromoter8.2100%8322160
HIMANSHU BAIDPromoter7.8000%7907624
QUANT MUTUAL FUND - QSIF HYBRID LONG-SHORT FUNDPublic4.6100%4673549

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 62.42% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 5.91% to 5.57% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 8.84% to 9.61% in Jun 2026 qtr

8 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 52 insider trades, 2 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
17 Aug 2023 RISHI BAID Director Sell 0 ₹0
14 Aug 2023 RISHI BAID Director Sell 0 ₹0
1 Apr 2022 RISHI BAID Director Sell 0 ₹0
29 Mar 2022 RISHI BAID Director Sell 0 ₹0
28 Mar 2022 RISHI BAID Director Sell 0 ₹0
1 Jul 2021 VCB TRADING LLP Promoter group Sell 0 ₹0
11 Mar 2020 JAS KARAN SANCHETI OSWALj Key managerial personnel Buy 0 ₹0
11 Mar 2020 NIDHI OSWAL (DAUGHTER OF CFO) Immediate relative Sell 0 ₹0
11 Mar 2020 JAS KARAN SANCHETI OSWALj Key managerial personnel Sell 0 ₹0
27 Dec 2019 M/S. POLYCURE MARTECH LIMITED Promoter group Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
16 Jan 2026 SMALLCAP WORLD FUND INC Bulk Sell 950,000 1645.0000 NSE
16 Jan 2026 SMALLCAP WORLD FUND INC Bulk Sell 887,064 1645.0000 BSE
9 Oct 2025 GOLDMAN SACHS BANK EUROPE SE - ODI Block Buy 264,142 1902.0000 NSE
9 Oct 2025 GOLDMAN SACHS (SINGAPORE) PTE - ODI Block Sell 264,142 1902.0000 NSE
21 Feb 2024 LIGHTHOUSE INDIA III EQUITY INVESTORSLIMITED Bulk Sell 1,290,939 1550.0600 BSE
25 Jan 2024 SOCIETE GENERALE Block Buy 101,686 1450.7000 BSE
25 Jan 2024 BNP PARIBAS ARBITRAGE Block Sell 101,686 1450.7000 BSE
27 Mar 2017 NILAYKUMAR VINODKUMAR DAGA Bulk Buy 567,066 228.3500 BSE
27 Mar 2017 NIRAJKUMAR VINODKUMAR DAGA NRO Bulk Sell 567,076 228.3500 BSE
24 Mar 2017 VARUN PRAMOD DAGA Bulk Buy 1,500,000 265.0000 NSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 3.5000 — —

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
7 Aug 2026 Financial Results/Other business matters Yes
25 May 2026 Financial Results/Dividend/Other business matters Yes
5 Feb 2026 Financial Results/Other business matters Yes
8 Nov 2025 Financial Results/Other business matters Yes
8 Aug 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Poly Medicure Ltd - 531768 - Closure of Trading Window
21 Sep 2026 Company Update Poly Medicure Ltd - 531768 - Intimation For The Schedule Of Investors/Analysts Call/Meet.
18 Sep 2026 Company Update Poly Medicure Ltd - 531768 - Intimation For The Schedule Of Investors/Analysts Call/Meet.
5 Sep 2026 AGM/EGM Poly Medicure Ltd - 531768 - Shareholder Meeting / Postal Ballot-Outcome of AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (20.4%)
  • Low financial leverage (Debt/Equity 0.11)
  • Comfortable interest coverage (31.0x)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (50.5) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Poly Medicure Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.